Sign in

CIK 0001802768

  • Large accelerated filer

Royalty Pharma plc

Sign in to watch
Ticker
RPRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+1 212-883-0200
Business address
110 EAST 59TH STREET, NEW YORK, NY, 10022
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$32,573,345
in 6 filings, $32.6M under 10b5-1 plans

Net −$32,573,345. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 15 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-05 HODGSON DAVID C Director Grant or award +4,545 37,873
2025-05-13 HODGSON DAVID C Director Grant or award +7,614 33,328
2024-06-07 HODGSON DAVID C Director Grant or award +9,293 25,714
2023-06-23 HODGSON DAVID C Director Grant or award +7,747 16,421
2022-07-08 HODGSON DAVID C Director Grant or award +2,346 8,674
2022-06-24 HODGSON DAVID C Director Grant or award +6,328 6,328

Page 1 of 1 · 6 trades